RBC Capital Reiterates Outperform Rating on Vertex Pharmaceuticals Incorporated (VRTX)
Rating Change RBC Capital analysts reiterated a Outperform rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on July 07, 2026. Market Context Vertex Pharmaceuticals…
Read more
